← Back to Search

Behavioral Intervention

Caring Contacts for Suicide Prevention (SPRING Trial)

N/A
Recruiting
Led By Anna K Radin, DrPH, MPH
Research Sponsored by St. Luke's Health System, Boise, Idaho
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, 12 months
Awards & highlights

SPRING Trial Summary

This trial compares 3 approaches to preventing suicide: 2-way texts, 1-way texts & enhanced usual care to see which is most effective.

Who is the study for?
The SPRING Trial is for adolescents (12-17 years) and adults (18+) who show signs of suicide risk based on the Columbia Suicide Severity Rating Scale or provider notes. Participants must be able to communicate via text, phone calls, and emails in English. Those with hearing impairments can receive accommodations.Check my eligibility
What is being tested?
This trial tests suicide prevention strategies by comparing two-way vs. one-way Caring Contacts text messages against enhanced usual care to see which is more effective in preventing suicide among at-risk individuals.See study design
What are the potential side effects?
Since this trial involves communication-based interventions rather than medical treatments, there are no direct physical side effects expected from participating.

SPRING Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Suicidal behavior
Secondary outcome measures
Outpatient mental health treatment
Suicide attempts
Suicide ideation
+1 more
Other outcome measures
All-cause ED utilization and hospitalizations
All-cause mortality
Completed suicide
+6 more

SPRING Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Two-Way Caring Contacts Texts (CC2)Experimental Treatment1 Intervention
In addition to receiving enhanced usual care as described below, a series of 25 standardized outgoing Caring Contacts text messages will be sent to participants randomized to the CC2 intervention arm through our online texting platform. To remind participants that they can respond, the outgoing texts will periodically invite replies in a non-demanding way, e.g., "Hope you're doing well this week, Anna. Feel free to text me back if you feel like it, I'm here for you." Responses to CC2 participant replies will be unscripted and individually tailored.
Group II: One-Way Caring Contacts Texts (CC1)Experimental Treatment1 Intervention
In addition to receiving enhanced usual care as described below, CC1 participants will be sent 25 caring texts, such as "Even though know we do not personally know each other, we truly value your wellbeing and are thinking of you. If you'd like to connect with someone, feel free to call or text 988 anytime - their team would be happy to hear from you." CC1 participants will not be able to reply to the texts and the online texting platform will block incoming messages. This will be clearly communicated to CC1 participants during the informed consent process and they will be asked to sign off on understanding this and other key points before enrolling in the study.
Group III: Enhanced Usual Care (UC)Active Control1 Intervention
Participants randomized to the UC arm will receive best available usual care from the health system, such as standardized clinical assessments, the safety planning intervention or other intervention(s), appropriate referrals and/or medication management through a system wide electronic health record system-assisted suicide care clinical workflow. Usual care will vary based on patient clinical needs, availability of providers/staff, and provider clinical judgment. Following study enrollment, all participants will be given a list of resources, offered a warm hand-off to 988, and encouragement to call or text 988 as needed. During the baseline survey, participants will have the opportunity to opt into a call from the follow-up team to develop or revise a safety plan.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Caring Contacts
2020
N/A
~250

Find a Location

Who is running the clinical trial?

University of WashingtonOTHER
1,741 Previous Clinical Trials
1,846,917 Total Patients Enrolled
6 Trials studying Suicide Prevention
4,047 Patients Enrolled for Suicide Prevention
American Foundation for Suicide PreventionOTHER
33 Previous Clinical Trials
8,926 Total Patients Enrolled
5 Trials studying Suicide Prevention
222 Patients Enrolled for Suicide Prevention
Idaho Crisis & Suicide HotlineUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there remaining slots for participants in this experiment?

"Reports on clinicaltrials.gov indicate that recruitment for this experiment has been suspended, with the trial having initially posted on December 13th 2023 and lastly updated November 10th 2023. Fortunately, there are currently 228 other trials actively looking to recruit new participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Comparing Suicide Prevention Interventions to Guide Follow-up Care: The SPRING Trial
Anna Radin 2023. "Comparing Suicide Prevention Interventions to Guide Follow-up Care: The SPRING Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06128239.
All > Meridian
~566 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top